Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody
Latest Information Update: 01 Feb 2024
At a glance
- Drugs Obinutuzumab (Primary) ; Rituximab
- Indications Follicular lymphoma
- Focus Therapeutic Use
- Acronyms FORTplus
- 10 Jul 2022 Status changed from not yet recruiting to recruiting.
- 16 May 2022 Status changed from recruiting to not yet recruiting.
- 16 May 2022 Planned initiation date changed from 1 Dec 2021 to 1 Jun 2022.